These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4027115)

  • 1. Attempts to phenotype human liver samples in vitro for debrisoquine 4-hydroxylase activity.
    Boobis AR; Hampden CE; Murray S; Beaune P; Davies DS
    Br J Clin Pharmacol; 1985 Jun; 19(6):721-9. PubMed ID: 4027115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism in drug oxidation: in vitro studies of human debrisoquine 4-hydroxylase and bufuralol 1'-hydroxylase activities.
    Boobis AR; Murray S; Hampden CE; Davies DS
    Biochem Pharmacol; 1985 Jan; 34(1):65-71. PubMed ID: 3966916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufuralol 1'-hydroxylase activity of the rat. Strain differences and the effects of inhibitors.
    Boobis AR; Seddon CE; Davies DS
    Biochem Pharmacol; 1986 Sep; 35(17):2961-5. PubMed ID: 3741485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
    McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
    Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling.
    Wolff T; Distlerath LM; Worthington MT; Groopman JD; Hammons GJ; Kadlubar FF; Prough RA; Martin MV; Guengerich FP
    Cancer Res; 1985 May; 45(5):2116-22. PubMed ID: 3921236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenacetin O-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine?
    Kahn GC; Boobis AR; Brodie MJ; Toverud EL; Murray S; Davies DS
    Br J Clin Pharmacol; 1985 Jul; 20(1):67-76. PubMed ID: 4027138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver.
    Kahn GC; Boobis AR; Murray S; Brodie MJ; Davies DS
    Br J Clin Pharmacol; 1982 May; 13(5):637-45. PubMed ID: 7082530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.
    Speirs CJ; Murray S; Boobis AR; Seddon CE; Davies DS
    Br J Clin Pharmacol; 1986 Dec; 22(6):739-43. PubMed ID: 3567021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.
    Distlerath LM; Reilly PE; Martin MV; Davis GG; Wilkinson GR; Guengerich FP
    J Biol Chem; 1985 Jul; 260(15):9057-67. PubMed ID: 4019462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
    Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
    Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of human cytochrome P-450.
    Guengerich FP; Umbenhauer DR; Churchill PF; Beaune PH; Böcker R; Knodell RG; Martin MV; Lloyd RS
    Xenobiotica; 1987 Mar; 17(3):311-6. PubMed ID: 3577206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.
    Kobayashi S; Murray S; Watson D; Sesardic D; Davies DS; Boobis AR
    Biochem Pharmacol; 1989 Sep; 38(17):2795-9. PubMed ID: 2775304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human liver debrisoquine 4-hydroxylase: test for specificity toward various monooxygenase substrates and model of the active site.
    Wolff T; Distlerath LM; Worthington MT; Guengerich FP
    Arch Toxicol; 1987; 60(1-3):89-90. PubMed ID: 3619650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of cytochrome P450IID6 (debrisoquin 4-hydroxylase) by flecainide in vitro and in vivo.
    Haefeli WE; Bargetzi MJ; Follath F; Meyer UA
    J Cardiovasc Pharmacol; 1990 May; 15(5):776-9. PubMed ID: 1692938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6.
    Mankowski DC
    Drug Metab Dispos; 1999 Sep; 27(9):1024-8. PubMed ID: 10460802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufI, P450db1) catalyzing debrisoquine 4-hydroxylation.
    Fonne-Pfister R; Bargetzi MJ; Meyer UA
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1144-50. PubMed ID: 3500719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
    Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
    J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debrisoquine 4-monooxygenase and bufuralol 1'-monooxygenase activities in bovine and rabbit tissues.
    Matsuo Y; Iwahashi K; Ichikawa Y
    Biochem Pharmacol; 1992 May; 43(9):1911-9. PubMed ID: 1596280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.